Clonidine-induced growth hormone and growth-hormone-releasing hormone release is mediated by tachykinin NK2 receptors in sheep

Pharmacology

Volumn 89, Issue 5-6, 2012, Pages 270-274

  Lemamy, Guy Joseph ^a,b   Guillaume, Viviane ^a   Ndboko, Bndicte ^b   Mouecoucou, Justine ^c   Renard, Mireille ^a   Oliver, Charles ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b Departments of Biochemistry and Cellular Biology   (Gabon)

^c Universite des Sciences de la Sante   (Gabon)

Author keywords

Clonidine; Growth hormone; Growth hormone releasing hormone; Sheep; Tachykinin

Indexed keywords

CLONIDINE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; NEUROKININ 2 RECEPTOR; TACHYKININ;

ANIMAL EXPERIMENT; ARTICLE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; ISOTOPE LABELING; NONHUMAN; NOSE SURGERY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SHEEP;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; BENZAMIDES; CLONIDINE; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; MALE; PIPERIDINES; QUINUCLIDINES; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2; SHEEP;

EID: 84863753277     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000337382     Document Type: Article

References (23)

1. Manheim D, Paalzow L, Hokfelt B: Plasma clonidine in relation to blood pressure, catecholamines and rennin activity during long-term treatment of hypertension. Clin Pharmacol Ther 1982; 31: 445-451.
2. Hunt RD, Minderaa RB, Cohen DJ: Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial. J Am Acad Child Psychiatry 1985; 24: 617-629.
3. Steingard R, Biederman J, Spencer T, Wilens T, Gonzalez A: Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders. J Am Acad Child Adolesc Psychiatry 1993; 32: 350-353.
4. Leckman JF, Anderson GM, Cohen DJ, Ort S, Harcherick DF, Hoder EL, Shaywitz BA: Whole blood serotonin and tryptophan levels in Tourette's disorder: effects of acute and chronic clonidine treatment. Life Sci 1984 35: 2497-2503.
5. Leckman JF, Detlor J, Harcherick DF, Ort S, Shatwitz BA, Cohen DJ: Short-and long-term treatment of Tourette's syndrome with clonidine: a clinical perspective. Neurology 1985; 35: 343-351.
6. Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ: Clonidine treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 1991; 48: 324-328.
7. Hewlett WA, Vinogradov S, Agras WS: Clomipramine, clonazepam and clonidine treatment of obsessive-compulsive disorder. J Clin Psychopharmacol 1992; 12: 420-430.
8. Lal S, Tolis G, Martin JB, Brown GM, Guyda H: Effect of growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone and thyroid-stimulating hormone in the serum of normal men. J Clin Endocrinol Metab 1975; 41: 827-832.
9. Leckman JF, Cohen DJ, Gertner JM, Ort S, Harcherik DF: Growth hormone response to clonidine in children ages 4-17: Tourette's syndrome vs children with short stature. J Am Acad Child Psychiatry 1984; 23: 174-181.
10. Pintor C, Corda R, Puggioni R, Cella SG, Locatelli V, Loche S, Müller EE: Clonidine accelerates growth in children with impaired growth hormone secretion. Lancet 1985; 325: 1482-1485.
11. Magnan E, Cataldi M, Guilluame V, Mazzochi L, Dutour A, Razafindraibe H, Sauze N, Renard M, Oliver C: Role of growth hormone (GH)-releasing hormone and somatostatin in the mediation of clonidine-induced GH release in sheep. Endocrinology 1994; 134: 562-567.
12. Locatelli A, Caraty A: Approche transnasale du système porte hypophysaire chez le bélier:application à l'étude des neurosécrétions. Sci Tech Anim Lab 1987; 2: 185-190.
13. Hunter WM, Greenwood FC: Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 1962; 194: 495-496.
14. Marchalonis JJ: An enzymic method for the trace iodination of immunoglobulins and other proteins. Biochem J 1969; 113: 299-305.
15. Magnan E, Cataldi M, Guillaume V, Mazzocchi L, Dutour A, Conte-Devolx B, Giraud P, Oliver C: Neostigmine stimulates growthhormone-releasing hormone release into hypophysial portal blood of conscious sheep. Endocrinology 1993; 132: 1247-1251.
16. Louis JC, Rougeot C, Bepoldin O, Vulliez B, Mandel P, Dray F: Presence of somatostatine, enkephalins and substance P-like peptides in cultured neurons from embryonic chick cerebral hemispheres. J Neurochem 1983; 41: 930-938.
17. Mazzola-Pomietto P, Aulakh CS, Murphy DL: The NMDA receptor complex modulates clonidine-induced increases in growth hormone levels in rats. Pharmacol Biochem Behav 1995; 50: 305-307.
18. Nakanishi S: Mammalian tachykinin receptors. Annu Rev Neurosci 1991; 14: 123-126.
19. Pennefather JN, Lecci A, Candenas ML, Patak E, Pinto FM, Maggi CA: Tachykinin and tachykinin receptors: a growing family. Life Sci 2004; 74: 1445-1463.
20. Rudolph CD, Kaplan SL, Ganong WF: Sites at which clonidine acts to affect blood pressure and the secretion of renin, growth hormone and ACTH. Neuroendocrinology 1980; 31: 121-128.
21. Margoul R, Ontoniente B, Benselloun W, Tramu G: Tachykinergic afferents to the rat arcuate nucleus. A combined immunohistochemical and retrograde tracing study. Peptides 1993; 14: 275-286.
22. Yamauchi N, Shibasaki T, Ling N, Demura H: In vitro release of growth hormone-releasing factor (GRF) from the hypothalamus: somatostatin inhibits GRF release. Regul Pept 1991; 33: 71-78.
23. Daikoku S, Hisano S, Kawano H, Chikamori-Aoyama M, Kagotani Y, Zhang R, Chiara K: Ultrastructure evidence for neuronal regulation of growth hormone secretion. Neuroendocrinology 1988; 47: 405-415.